Compass Therapeutics Inc (CMPX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Gross Profit | 18,500 | 18,610 | 15,040 | 16,740 | 14,730 |
| Operating Expenses | 540 | 490 | 630 | 650 | 720 |
| Operating Income | -540 | -490 | -630 | -650 | -720 |
| Pre-tax Income | -540 | -490 | -630 | -650 | -720 |
| Net Income Continuous | -540 | -490 | -630 | -650 | -720 |
| Net Income | $-540 | $-490 | $-630 | $-650 | $-720 |
| EBITDA(a) | $-90 | $N/A | $-400 | $-60 | $-370 |